Epstein Secrets

tary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University), Pete LuPiba (Military Interstate Children's Compact Commission), Michelle Norman, Jennifer Barnhill, and Grace Kim (all Partners in PROMISE), Jes

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

etary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University), Pete LuPiba (Military Interstate Children's Compact Commission), Michelle Norman, Jennifer Barnhill, and Grace Kim (all Partners in PROMISE), Jes

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

tary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University), Pete LuPiba (Military Interstate Children's Compact Commission), Michelle Norman, Jennifer Barnhill, and Grace Kim (all Partners in PROMISE), Jes

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

tary of Defense Mark Esper keynotes, with panelists including bipartisan Reps. Trent Kelly and Chrissy Houlahan, as well as Jennifer Drake Patrick (George Mason University), Pete LuPiba (Military Interstate Children's Compact Commission), Michelle Norman, Jennifer Barnhill, and Grace Kim (all Partners in PROMISE), Jes

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,